Knowledge, attitudes and perceptions regarding lymphatic filariasis: study on systematic noncompliance with mass drug administration

被引:5
|
作者
Cabral, Silvia [1 ]
Bonfim, Cristine [2 ,3 ]
Oliveira, Rosalira [2 ]
Oliveira, Paula [4 ,5 ]
Guimaraes, Terezinha [4 ]
Brandao, Eduardo [5 ]
Aguiar-Santos, Ana Maria [5 ]
Medeiros, Zulma [5 ,6 ]
机构
[1] Fundacao Oswaldo Cruz, Ctr Pesquisa Aggeu Magalhaes, Programa Doutorado Saude Publ, Recife, PE, Brazil
[2] Fundacao Joaquim Nabuco, Dept Pesquisa Social, Recife, PE, Brazil
[3] Univ Fed Pernambuco, Programa Posgrad Integrada Saude Colet, Recife, PE, Brazil
[4] Secretaria Saude Olinda, Recife, PE, Brazil
[5] Fundacao Oswaldo Cruz, Ctr Pesquisa Aggeu Magalhaes, Dept Parasitol, Recife, PE, Brazil
[6] Univ Pernambuco, Inst Ciencias Biol, Recife, PE, Brazil
关键词
Lymphatic filariasis; Control program; Mass drug administration; Systematic noncompliance; URBAN AREAS; EPIDEMIOLOGIC SITUATION; BANCROFTIAN FILARIASIS; ENDEMIC AREA; PROGRAM; ELIMINATION; COVERAGE; BRAZIL; INDIA; DISTRICT;
D O I
10.1590/S1678-9946201759023
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The aim of this study was to investigate the epidemiological characteristics, antigenic profile, perceptions, attitudes and practices of individuals who have been systematically noncompliant in mass drug administration (MDA) campaigns targeting lymphatic filariasis, in the municipality of Olinda, State of Pernambuco, Northeastern Brazil. A pretested questionnaire was used to obtain information on socioenvironmental demographics, perceptions of lymphatic filariasis and MDA, and reasons for systematic noncompliance with treatment. A rapid immunochromatographic test (ICT) was performed during the survey to screen for filariasis. It was found that the survey subjects knew about filariasis and MDA. Filariasis was identified as a disease (86.2%) and 74.4% associated it with the presence of swelling in the legs. About 80% knew about MDA, and the main source of information was healthcare workers (68.3%). For men the main reasons for systematic noncompliance with MDA were that "the individual had not received the medication" (p=0.03) and for women "the individual either feared experiencing adverse reactions". According to the ICT, the prevalence of lymphatic filariasis was 2%. The most important causes of systematic noncompliance were not receiving the drug and fear of side-effects. For successful implementation of MDA programs, good planning, educational campaigns promoting the benefits of MDA, adoption of measures to minimize the impact of adverse effects and improvement of drug distribution logistics are needed.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Compliance and efficacy of mass drug administration for elimination of lymphatic filariasis in Egypt
    El Setouhy, Maged
    Aziz, Khaled Abdel
    Ahmed, Ehab S.
    Ramzy, Reda M.
    Weil, Gary J.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 73 (06): : 176 - 176
  • [22] Challenges in mass drug administration for treating lymphatic filariasis in Papua, Indonesia
    Navneet Bhullar
    Jacob Maikere
    Parasites & Vectors, 3
  • [23] Coverage of, and compliance with, mass drug administration under the programme to eliminate lymphatic filariasis in India: a systematic review
    Babu, Bontha V.
    Babu, Gopalan R.
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2014, 108 (09) : 538 - 549
  • [24] Using knowledge, attitudes and practice (KAP) surveys on lymphatic filariasis to prepare a health promotion campaign for mass drug administration in Alor District, Indonesia
    Krentel, Alison
    Fischer, Peter
    Manoempil, Paul
    Supali, Taniawati
    Servais, Gerard
    Ruckert, Paul
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2006, 11 (11) : 1731 - 1740
  • [25] Perceptions, knowledge, attitudes and practices for the prevention and control of lymphatic filariasis in Conakry, Republic of Guinea
    Kouassi, Bernard L.
    Barry, Aboulaye
    Heitz-Tokpa, Kathrin
    Krauth, Stefanie J.
    Goepogui, Andre
    Balde, Mamadou S.
    Barry, Oumar
    Niamey, Marie L.
    Bockarie, Moses J.
    Koudou, Benjamin G.
    Utzinger, Jurg
    ACTA TROPICA, 2018, 179 : 109 - 116
  • [26] Directly observed treatment increases drug compliance in lymphatic filariasis mass drug administration
    Rosanti, Tutik Ida
    Mardihusodo, Sugeng Juwono
    Artama, Wayan T.
    UNIVERSA MEDICINA, 2016, 35 (02) : 119 - 127
  • [27] THE EFFICACY OF TRIPLE DRUG THERAPY IN MASS DRUG ADMINISTRATION TO REDUCE LYMPHATIC FILARIASIS IN HAITI
    Hast, Marisa A.
    Dubray, Christine L.
    Sircar, Anita D.
    De Rochars, Madsen Beau
    Bogus, Joshua
    Direny, Abdel N.
    Ernest, Jean Romuald
    Fayette, Carl
    O'Brian, Katiuscia
    Goss, Charles W.
    Sabin, Daniel Frantz
    Wiegand, Ryan
    Lemoine, Jean Frantz
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2019, 101 : 198 - 198
  • [28] Assessing knowledge about lymphatic filariasis and the implementation of mass drug administration amongst drug deliverers in three districts/cities of Indonesia
    Christiana R. Titaley
    Rita Damayanti
    Nugroho Soeharno
    Anifatun Mu’asyaroh
    Mark Bradley
    Tim Lynam
    Alison Krentel
    Parasites & Vectors, 11
  • [29] Population pharmacokinetic model of ivermectin in mass drug administration against lymphatic filariasis
    Alshehri, Abdullah
    Chhonker, Yashpal S.
    Bala, Veenu
    Edi, Constant
    Bjerum, Catherine M.
    Koudou, Benjamin G.
    John, Lucy N.
    Mitja, Oriol
    Marks, Michael
    King, Christopher L.
    Murry, Daryl J.
    PLOS NEGLECTED TROPICAL DISEASES, 2023, 17 (06):
  • [30] The Health and Economic Burdens of Lymphatic Filariasis Prior to Mass Drug Administration Programs
    Mathew, Christopher G.
    Bettis, Alison A.
    Chu, Brian K.
    English, Mike
    Ottesen, Eric A.
    Bradley, Mark H.
    Turner, Hugo C.
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (12) : 2561 - 2567